Rajesh Gupta, MD
Interventional Cardiology · Toledo, OHNPI 1477741197
Payments from drug & device makers
What this record shows
Abbott accounts for 73.8% of it on its own, with 10 other manufacturers making up the rest. Reporting peaked in 2023 at $1,331 and has fallen 78.3% since, to $289 in 2025. That places this record below the midpoint for interventional cardiology clinicians in OH, where the typical reported total is $4,547.
Across 27 payments — averaging $76.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$2K
- Kestra Medical Technology Services, Inc.$123
- E.r. Squibb & Sons, L.L.C.$104
- Heartflow, Inc.$75
- Abiomed$66
- Inari Medical, Inc.$51
- plus $121 from 5 others
Across 33 payments — averaging $9677.81 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Abbott$237K
- Novartis$60K
- EKOS Corporation$16K
- Boston Scientific$8K
What the payments were for
- Travel & lodging$1,12555%
- Food & beverage$93245%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 11 | $1,518 |
| Kestra Medical Technology Services, Inc. | 2 | $123 |
| E.r. Squibb & Sons, L.L.C. | 2 | $104 |
| Heartflow, Inc. | 2 | $75 |
| Abiomed | 2 | $66 |
| Inari Medical, Inc. | 2 | $51 |
| Novartis | 2 | $36 |
| Biosense Webster, Inc. | 1 | $31 |
| Terumo Medical Corporation | 1 | $21 |
| Novo Nordisk | 1 | $18 |
| AstraZeneca | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MitraClip$1,150
- TRICLIP$176
- Assure WCD$108
How this compares
$2,057 in reported general payments places this provider in the 30th percentile of 256 interventional cardiology providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 266 | $256,820 |
| EntrestoSacubitril/Valsartan | 86 | $130,341 |
| XareltoRivaroxaban | 98 | $104,701 |
| FarxigaDapagliflozin Propanediol | 70 | $81,009 |
| Repatha SureclickEvolocumab | 85 | $67,685 |
| JardianceEmpagliflozin | 45 | $55,546 |
| Praluent PenAlirocumab | 17 | $24,105 |
| Candesartan Cilexetil | 236 | $15,939 |
| Icosapent Ethyl | 21 | $15,003 |
| VascepaIcosapent Ethyl | 22 | $11,448 |
| Ezetimibe | 192 | $6,622 |
| Varenicline Tartrate | 26 | $6,349 |
| Atorvastatin Calcium | 412 | $4,945 |
| Metoprolol Succinate | 294 | $3,818 |
| ClopidogrelClopidogrel Bisulfate | 247 | $3,338 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| NovartisEntresto | $36 | $130,34186 claims |
| AstraZenecaFarxiga | $14 | $81,00970 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 30th percentile of 256 interventional cardiology providers in Ohio.
Other interventional cardiology in Toledo
- William ColyerToledo$139K
- P Kasi RamanathanToledo$101K
- Stephanie YounesToledo$49K
- Gary AnselColumbus$3.3M
- John CheathamColumbus$1.4M
- Carlos Sanchez SotoColumbus$1.1M
- Steven YakubovColumbus$907K
- Timothy HenryCincinnati$605K
- Mitchell SilverColumbus$562K
- John PhillipsColumbus$410K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.